HHS Secretary Robert F. Kennedy Jr. is defending a FY2027 budget that would cut HHS spending by 12.5%, or $15.8 billion, including a $5 billion NIH reduction — but hostile hearings on Capitol Hill suggest Congress is unlikely to go along, signaling continued federal support for research, public health programs and safety-net services clinicians rely on. The proposal would also eliminate the Low Income Home Energy Assistance Program and consolidate multiple offices into a new Administration for a Healthy America, with potentially broad effects on how prevention, maternal health, HIV and behavioral health programs are administered.

The Move

• Kennedy's budget would shrink HHS by $15.8 billion from FY2026 levels.

• The biggest named cut is $5 billion from NIH, while reducing its institutes and centers from 27 to 22.

• The plan would also eliminate LIHEAP, saving $4 billion, and fold several health offices into the new Administration for a Healthy America, which HHS says would save $5 billion.

• Lawmakers in both chambers sharply criticized the proposal during hearings, with key appropriators signaling little appetite to enact it.

Why It Matters for Care

• For clinicians, the immediate implication is that major cuts to NIH-backed research, public health infrastructure and related programs are more likely to be blunted than fully enacted.

• If Congress did adopt the plan, practices and health systems could see downstream effects on clinical trials, translational research, maternal health initiatives, HIV services, behavioral health coordination and opioid-related programs.

• Eliminating LIHEAP could also affect medically vulnerable patients who depend on safe home heating and cooling, with knock-on effects for chronic disease management and winter health risks.

• Even if the cuts fail, the reorganization push could still reshape how federal programs are coordinated and how grants or technical support reach frontline care settings.

Between The Lines

• Kennedy is framing the proposal as a debt- and efficiency-driven overhaul, arguing HHS has too many duplicative offices and programs that do not communicate well.

• Congress, by contrast, tends to treat public health and biomedical research cuts as politically toxic, especially when opponents can tie them to delayed cures, canceled studies or reduced family supports.

• The deeper fight is not just over line items but over the size and role of federal health agencies — and whether streamlining improves performance or simply reduces capacity.

• Even this proposal is not a pure austerity budget: some areas, including nutrition services, food safety, chemical regulation, and infection prevention, would still receive increases.

What To Watch

• Watch the House and Senate appropriations process, where Congress — not HHS — will decide which cuts, if any, survive.

• Key signals will come from appropriators such as Rep. Rosa DeLauro and senators on the HELP Committee, who have already shown resistance.

• Monitor whether HHS tries to advance parts of the reorganization administratively even without full budget approval.

• For clinicians and academic centers, the practical milestones are NIH funding negotiations, grant outlooks, and whether categorical programs are preserved, merged or delayed in the final FY2027 package.

Source: Reason